Ravi C Dara/LinkedIn
Oct 1, 2026, 13:56
Ravi C Dara: Advancing Red Cell Exchange in Sickle Cell Disease
Ravi C Dara, Consultant Physician Transfusion Medicine at Sheikh Shakhbout Medical City, shared a post on LinkedIn:
“Grateful for the opportunity to speak at ADHAR 2026 – the 3rd Abu Dhabi Haematology Annual Review – on ‘Red Cell Exchange in Sickle Cell Disease: The Case for Early, Optimised Therapy.’
It was a privilege to share our experience from the apheresis programme, and especially rewarding to see such active engagement from the audience – with several thoughtful questions following the talk.
Thank you to the Kourosh Lotfi, Kayane Mheidly, Aydah AlAwadhi for the invitation, and to everyone who attended and contributed to the discussion.”

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines